← 產業報告目錄
Antiasthmatic Drug Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 146報告編號 APO-7f8f17be05
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Antiasthmatic Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Antiasthmatic Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Antiasthmatic Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Antiasthmatic Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Antiasthmatic Drug include Ruiyang Pharmaceutical Co., Ltd, Novartis AG, Roche, Lunan Pharmaceutical Group Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, GlaxoSmithKline, Fuhe Group, Chengdu Huayu Pharmaceutical Co., Ltd and AstraZeneca, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antiasthmatic Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Antiasthmatic Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antiasthmatic Drug Market by Company
Ruiyang Pharmaceutical Co., Ltd
Novartis AG
Roche
Lunan Pharmaceutical Group Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
GlaxoSmithKline
Fuhe Group
Chengdu Huayu Pharmaceutical Co., Ltd
AstraZeneca
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Kyorin Pharmaceutical Co.,Ltd.
Kissei Pharmaceutical Co.Ltd.
Daiichi Sankyo Company Limited
Covis Pharmaceutical Inc
Chiesi GmbH
Boehringer Ingelheim Pharma GmbH&Co.KG
Akorn Pharmaceutical Co.Ltd.
ABC Farmaceutici Spa
Antiasthmatic Drug Segment by Type
Anti-allergic Antiasthmatic
Anti-inflammatory Antiasthmatic
Bronchodilators
Antiasthmatic Drug Segment by Application
Hospital
Clinic
Other
Antiasthmatic Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiasthmatic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiasthmatic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiasthmatic Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Antiasthmatic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Antiasthmatic Drug by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Anti-allergic Antiasthmatic
2.2.3 Anti-inflammatory Antiasthmatic
2.2.4 Bronchodilators
2.3 Antiasthmatic Drug by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Hospital
2.3.3 Clinic
2.3.4 Other
2.4 Assumptions and Limitations
3 Antiasthmatic Drug Breakdown Data by Type
3.1 Global Antiasthmatic Drug Historic Market Size by Type (2021-2026)
3.2 Global Antiasthmatic Drug Forecasted Market Size by Type (2027-2032)
4 Antiasthmatic Drug Breakdown Data by Application
4.1 Global Antiasthmatic Drug Historic Market Size by Application (2021-2026)
4.2 Global Antiasthmatic Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Antiasthmatic Drug Market Perspective (2021-2032)
5.2 Global Antiasthmatic Drug Growth Trends by Region
5.2.1 Global Antiasthmatic Drug Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Antiasthmatic Drug Historic Market Size by Region (2021-2026)
5.2.3 Antiasthmatic Drug Forecasted Market Size by Region (2027-2032)
5.3 Antiasthmatic Drug Market Dynamics
5.3.1 Antiasthmatic Drug Industry Trends
5.3.2 Antiasthmatic Drug Market Drivers
5.3.3 Antiasthmatic Drug Market Challenges
5.3.4 Antiasthmatic Drug Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Antiasthmatic Drug Players by Revenue
6.1.1 Global Top Antiasthmatic Drug Players by Revenue (2021-2026)
6.1.2 Global Antiasthmatic Drug Revenue Market Share by Players (2021-2026)
6.2 Global Antiasthmatic Drug Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Antiasthmatic Drug Head Office and Area Served
6.4 Global Antiasthmatic Drug Players, Product Type & Application
6.5 Global Antiasthmatic Drug Manufacturers Established Date
6.6 Global Antiasthmatic Drug Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Antiasthmatic Drug Market Size (2021-2032)
7.2 North America Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Antiasthmatic Drug Market Size by Country (2021-2026)
7.4 North America Antiasthmatic Drug Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Antiasthmatic Drug Market Size (2021-2032)
8.2 Europe Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Antiasthmatic Drug Market Size by Country (2021-2026)
8.4 Europe Antiasthmatic Drug Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Antiasthmatic Drug Market Size (2021-2032)
9.2 Asia-Pacific Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Antiasthmatic Drug Market Size by Country (2021-2026)
9.4 Asia-Pacific Antiasthmatic Drug Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Antiasthmatic Drug Market Size (2021-2032)
10.2 South America Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Antiasthmatic Drug Market Size by Country (2021-2026)
10.4 South America Antiasthmatic Drug Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Antiasthmatic Drug Market Size (2021-2032)
11.2 Middle East & Africa Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Antiasthmatic Drug Market Size by Country (2021-2026)
11.4 Middle East & Africa Antiasthmatic Drug Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Ruiyang Pharmaceutical Co., Ltd
12.1.1 Ruiyang Pharmaceutical Co., Ltd Company Information
12.1.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
12.1.3 Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026)
12.1.4 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
12.1.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments
12.2 Novartis AG
12.2.1 Novartis AG Company Information
12.2.2 Novartis AG Business Overview
12.2.3 Novartis AG Revenue in Antiasthmatic Drug Business (2021-2026)
12.2.4 Novartis AG Antiasthmatic Drug Product Portfolio
12.2.5 Novartis AG Recent Developments
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Business Overview
12.3.3 Roche Revenue in Antiasthmatic Drug Business (2021-2026)
12.3.4 Roche Antiasthmatic Drug Product Portfolio
12.3.5 Roche Recent Developments
12.4 Lunan Pharmaceutical Group Co., Ltd
12.4.1 Lunan Pharmaceutical Group Co., Ltd Company Information
12.4.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
12.4.3 Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026)
12.4.4 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Portfolio
12.4.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments
12.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd
12.5.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information
12.5.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
12.5.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026)
12.5.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
12.5.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2021-2026)
12.6.4 GlaxoSmithKline Antiasthmatic Drug Product Portfolio
12.6.5 GlaxoSmithKline Recent Developments
12.7 Fuhe Group
12.7.1 Fuhe Group Company Information
12.7.2 Fuhe Group Business Overview
12.7.3 Fuhe Group Revenue in Antiasthmatic Drug Business (2021-2026)
12.7.4 Fuhe Group Antiasthmatic Drug Product Portfolio
12.7.5 Fuhe Group Recent Developments
12.8 Chengdu Huayu Pharmaceutical Co., Ltd
12.8.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Information
12.8.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
12.8.3 Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026)
12.8.4 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
12.8.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
12.9 AstraZeneca
12.9.1 AstraZeneca Company Information
12.9.2 AstraZeneca Business Overview
12.9.3 AstraZeneca Revenue in Antiasthmatic Drug Business (2021-2026)
12.9.4 AstraZeneca Antiasthmatic Drug Product Portfolio
12.9.5 AstraZeneca Recent Developments
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Teva Pharmaceutical Industries Ltd Company Information
12.10.2 Teva Pharmaceutical Industries Ltd Business Overview
12.10.3 Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2021-2026)
12.10.4 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Portfolio
12.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
12.11 Mundipharma Pharmaceuticals Ltd.
12.11.1 Mundipharma Pharmaceuticals Ltd. Company Information
12.11.2 Mundipharma Pharmaceuticals Ltd. Business Overview
12.11.3 Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2021-2026)
12.11.4 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Portfolio
12.11.5 Mundipharma Pharmaceuticals Ltd. Recent Developments
12.12 MSD
12.12.1 MSD Company Information
12.12.2 MSD Business Overview
12.12.3 MSD Revenue in Antiasthmatic Drug Business (2021-2026)
12.12.4 MSD Antiasthmatic Drug Product Portfolio
12.12.5 MSD Recent Developments
12.13 Kyorin Pharmaceutical Co.,Ltd.
12.13.1 Kyorin Pharmaceutical Co.,Ltd. Company Information
12.13.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
12.13.3 Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2021-2026)
12.13.4 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Portfolio
12.13.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments
12.14 Kissei Pharmaceutical Co.Ltd.
12.14.1 Kissei Pharmaceutical Co.Ltd. Company Information
12.14.2 Kissei Pharmaceutical Co.Ltd. Business Overview
12.14.3 Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2021-2026)
12.14.4 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
12.14.5 Kissei Pharmaceutical Co.Ltd. Recent Developments
12.15 Daiichi Sankyo Company Limited
12.15.1 Daiichi Sankyo Company Limited Company Information
12.15.2 Daiichi Sankyo Company Limited Business Overview
12.15.3 Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2021-2026)
12.15.4 Daiichi Sankyo Company Limited Antiasthmatic Drug Product Portfolio
12.15.5 Daiichi Sankyo Company Limited Recent Developments
12.16 Covis Pharmaceutical Inc
12.16.1 Covis Pharmaceutical Inc Company Information
12.16.2 Covis Pharmaceutical Inc Business Overview
12.16.3 Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2021-2026)
12.16.4 Covis Pharmaceutical Inc Antiasthmatic Drug Product Portfolio
12.16.5 Covis Pharmaceutical Inc Recent Developments
12.17 Chiesi GmbH
12.17.1 Chiesi GmbH Company Information
12.17.2 Chiesi GmbH Business Overview
12.17.3 Chiesi GmbH Revenue in Antiasthmatic Drug Business (2021-2026)
12.17.4 Chiesi GmbH Antiasthmatic Drug Product Portfolio
12.17.5 Chiesi GmbH Recent Developments
12.18 Boehringer Ingelheim Pharma GmbH&Co.KG
12.18.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Information
12.18.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
12.18.3 Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2021-2026)
12.18.4 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Portfolio
12.18.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
12.19 Akorn Pharmaceutical Co.Ltd.
12.19.1 Akorn Pharmaceutical Co.Ltd. Company Information
12.19.2 Akorn Pharmaceutical Co.Ltd. Business Overview
12.19.3 Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2021-2026)
12.19.4 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
12.19.5 Akorn Pharmaceutical Co.Ltd. Recent Developments
12.20 ABC Farmaceutici Spa
12.20.1 ABC Farmaceutici Spa Company Information
12.20.2 ABC Farmaceutici Spa Business Overview
12.20.3 ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2021-2026)
12.20.4 ABC Farmaceutici Spa Antiasthmatic Drug Product Portfolio
12.20.5 ABC Farmaceutici Spa Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Antiasthmatic Drug Revenue Market Share by Type (2021-2026)
Table 7. Global Antiasthmatic Drug Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Antiasthmatic Drug Revenue Market Share by Type (2027-2032)
Table 9. Global Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Antiasthmatic Drug Revenue Market Share by Application (2021-2026)
Table 11. Global Antiasthmatic Drug Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Antiasthmatic Drug Revenue Market Share by Application (2027-2032)
Table 13. Global Antiasthmatic Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Antiasthmatic Drug Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Antiasthmatic Drug Market Share by Region (2021-2026)
Table 16. Global Antiasthmatic Drug Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Antiasthmatic Drug Market Share by Region (2027-2032)
Table 18. Antiasthmatic Drug Industry Trends
Table 19. Antiasthmatic Drug Industry Drivers
Table 20. Antiasthmatic Drug Industry Opportunities and Challenges
Table 21. Antiasthmatic Drug Market Restraints
Table 22. Global Top Antiasthmatic Drug Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Antiasthmatic Drug Revenue Market Share by Players (2021-2026)
Table 24. Global Antiasthmatic Drug Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Antiasthmatic Drug, Headquarters and Area Served
Table 26. Global Antiasthmatic Drug Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Antiasthmatic Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Antiasthmatic Drug Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Antiasthmatic Drug Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Antiasthmatic Drug Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Antiasthmatic Drug Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Antiasthmatic Drug Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Antiasthmatic Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Antiasthmatic Drug Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Antiasthmatic Drug Market Size by Country (2027-2032) & (US$ Million)
Table 45. Ruiyang Pharmaceutical Co., Ltd Company Information
Table 46. Ruiyang Pharmaceutical Co., Ltd Business Overview
Table 47. Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 48. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
Table 49. Ruiyang Pharmaceutical Co., Ltd Recent Developments
Table 50. Novartis AG Company Information
Table 51. Novartis AG Business Overview
Table 52. Novartis AG Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 53. Novartis AG Antiasthmatic Drug Product Portfolio
Table 54. Novartis AG Recent Developments
Table 55. Roche Company Information
Table 56. Roche Business Overview
Table 57. Roche Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 58. Roche Antiasthmatic Drug Product Portfolio
Table 59. Roche Recent Developments
Table 60. Lunan Pharmaceutical Group Co., Ltd Company Information
Table 61. Lunan Pharmaceutical Group Co., Ltd Business Overview
Table 62. Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 63. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Portfolio
Table 64. Lunan Pharmaceutical Group Co., Ltd Recent Developments
Table 65. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information
Table 66. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
Table 67. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 68. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
Table 69. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 73. GlaxoSmithKline Antiasthmatic Drug Product Portfolio
Table 74. GlaxoSmithKline Recent Developments
Table 75. Fuhe Group Company Information
Table 76. Fuhe Group Business Overview
Table 77. Fuhe Group Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 78. Fuhe Group Antiasthmatic Drug Product Portfolio
Table 79. Fuhe Group Recent Developments
Table 80. Chengdu Huayu Pharmaceutical Co., Ltd Company Information
Table 81. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
Table 82. Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 83. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
Table 84. Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
Table 85. AstraZeneca Company Information
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 88. AstraZeneca Antiasthmatic Drug Product Portfolio
Table 89. AstraZeneca Recent Developments
Table 90. Teva Pharmaceutical Industries Ltd Company Information
Table 91. Teva Pharmaceutical Industries Ltd Business Overview
Table 92. Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 93. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Portfolio
Table 94. Teva Pharmaceutical Industries Ltd Recent Developments
Table 95. Mundipharma Pharmaceuticals Ltd. Company Information
Table 96. Mundipharma Pharmaceuticals Ltd. Business Overview
Table 97. Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 98. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Portfolio
Table 99. Mundipharma Pharmaceuticals Ltd. Recent Developments
Table 100. MSD Company Information
Table 101. MSD Business Overview
Table 102. MSD Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 103. MSD Antiasthmatic Drug Product Portfolio
Table 104. MSD Recent Developments
Table 105. Kyorin Pharmaceutical Co.,Ltd. Company Information
Table 106. Kyorin Pharmaceutical Co.,Ltd. Business Overview
Table 107. Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 108. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Portfolio
Table 109. Kyorin Pharmaceutical Co.,Ltd. Recent Developments
Table 110. Kissei Pharmaceutical Co.Ltd. Company Information
Table 111. Kissei Pharmaceutical Co.Ltd. Business Overview
Table 112. Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 113. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
Table 114. Kissei Pharmaceutical Co.Ltd. Recent Developments
Table 115. Daiichi Sankyo Company Limited Company Information
Table 116. Daiichi Sankyo Company Limited Business Overview
Table 117. Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 118. Daiichi Sankyo Company Limited Antiasthmatic Drug Product Portfolio
Table 119. Daiichi Sankyo Company Limited Recent Developments
Table 120. Covis Pharmaceutical Inc Company Information
Table 121. Covis Pharmaceutical Inc Business Overview
Table 122. Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 123. Covis Pharmaceutical Inc Antiasthmatic Drug Product Portfolio
Table 124. Covis Pharmaceutical Inc Recent Developments
Table 125. Chiesi GmbH Company Information
Table 126. Chiesi GmbH Business Overview
Table 127. Chiesi GmbH Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 128. Chiesi GmbH Antiasthmatic Drug Product Portfolio
Table 129. Chiesi GmbH Recent Developments
Table 130. Boehringer Ingelheim Pharma GmbH&Co.KG Company Information
Table 131. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
Table 132. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 133. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Portfolio
Table 134. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
Table 135. Akorn Pharmaceutical Co.Ltd. Company Information
Table 136. Akorn Pharmaceutical Co.Ltd. Business Overview
Table 137. Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 138. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
Table 139. Akorn Pharmaceutical Co.Ltd. Recent Developments
Table 140. ABC Farmaceutici Spa Company Information
Table 141. ABC Farmaceutici Spa Business Overview
Table 142. ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2021-2026) & (US$ Million)
Table 143. ABC Farmaceutici Spa Antiasthmatic Drug Product Portfolio
Table 144. ABC Farmaceutici Spa Recent Developments
Table 145. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Antiasthmatic Drug Product Image
Figure 5. Global Antiasthmatic Drug Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Antiasthmatic Drug Market Share by Type: 2025 VS 2032
Figure 7. Anti-allergic Antiasthmatic Product
Figure 8. Anti-inflammatory Antiasthmatic Product
Figure 9. Bronchodilators Product
Figure 10. Global Antiasthmatic Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Antiasthmatic Drug Market Share by Application: 2025 VS 2032
Figure 12. Hospital Product
Figure 13. Clinic Product
Figure 14. Other Product
Figure 15. Global Antiasthmatic Drug Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global Antiasthmatic Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global Antiasthmatic Drug Market Share by Region: 2025 VS 2032
Figure 18. Global Antiasthmatic Drug Market Share by Players in 2025
Figure 19. Global Antiasthmatic Drug Manufacturers Established Date
Figure 20. Global Top 5 and 10 Antiasthmatic Drug Players Market Share by Revenue in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. North America Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America Antiasthmatic Drug Market Share by Country (2021-2032)
Figure 24. United States Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Canada Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Mexico Antiasthmatic Drug Market Share by Country (2021-2032)
Figure 27. Europe Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Europe Antiasthmatic Drug Market Share by Country (2021-2032)
Figure 29. Germany Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. France Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. U.K. Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Italy Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Spain Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Russia Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Netherlands Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Nordic Countries Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Antiasthmatic Drug Market Share by Country (2021-2032)
Figure 39. China Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Japan Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. South Korea Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Antiasthmatic Drug Market Share by Country (2021-2032)
Figure 44. Australia Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. China Taiwan Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Antiasthmatic Drug Market Share by Country (2021-2032)
Figure 49. Brazil Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Argentina Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Chile Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Colombia Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Peru Antiasthmatic Drug Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Ruiyang Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 55. Novartis AG Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 56. Roche Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 57. Lunan Pharmaceutical Group Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 58. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 60. Fuhe Group Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 61. Chengdu Huayu Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 62. AstraZeneca Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 63. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 64. Mundipharma Pharmaceuticals Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 65. MSD Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 66. Kyorin Pharmaceutical Co.,Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 67. Kissei Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 68. Daiichi Sankyo Company Limited Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 69. Covis Pharmaceutical Inc Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 70. Chiesi GmbH Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 71. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 72. Akorn Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
Figure 73. ABC Farmaceutici Spa Revenue Growth Rate in Antiasthmatic Drug Business (2021-2026)
提及公司
Ruiyang Pharmaceutical Co., LtdNovartis AGRocheLunan Pharmaceutical Group Co., LtdKaifeng Kangnuo Pharmaceutical Co., LtdGlaxoSmithKlineFuhe GroupChengdu Huayu Pharmaceutical Co., LtdAstraZenecaTeva Pharmaceutical Industries LtdMundipharma Pharmaceuticals Ltd.MSDKyorin Pharmaceutical Co.,Ltd.Kissei Pharmaceutical Co.Ltd.Daiichi Sankyo Company LimitedCovis Pharmaceutical IncChiesi GmbHBoehringer Ingelheim Pharma GmbH&Co.KGAkorn Pharmaceutical Co.Ltd.ABC Farmaceutici Spa
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們